Literature DB >> 22853031

Association of a HOXB13 variant with breast cancer.

Shaheen Alanee, Fergus Couch, Kenneth Offit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22853031      PMCID： PMC3926433          DOI： 10.1056/NEJMc1205138

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Germline mutations in HOXB13 and prostate-cancer risk.

Authors:  Charles M Ewing; Anna M Ray; Ethan M Lange; Kimberly A Zuhlke; Christiane M Robbins; Waibhav D Tembe; Kathleen E Wiley; Sarah D Isaacs; Dorhyun Johng; Yunfei Wang; Chris Bizon; Guifang Yan; Marta Gielzak; Alan W Partin; Vijayalakshmi Shanmugam; Tyler Izatt; Shripad Sinari; David W Craig; S Lilly Zheng; Patrick C Walsh; James E Montie; Jianfeng Xu; John D Carpten; William B Isaacs; Kathleen A Cooney
Journal:  N Engl J Med       Date:  2012-01-12       Impact factor: 91.245

2.  Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer.

Authors:  Piiha-Lotta Jerevall; Agneta Jansson; Tommy Fornander; Lambert Skoog; Bo Nordenskjöld; Olle Stål
Journal:  Breast Cancer Res       Date:  2010-07-22       Impact factor: 6.466

3.  A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.

Authors:  Xiao-Jun Ma; Zuncai Wang; Paula D Ryan; Steven J Isakoff; Anne Barmettler; Andrew Fuller; Beth Muir; Gayatry Mohapatra; Ranelle Salunga; J Todd Tuggle; Yen Tran; Diem Tran; Ana Tassin; Paul Amon; Wilson Wang; Wei Wang; Edward Enright; Kimberly Stecker; Eden Estepa-Sabal; Barbara Smith; Jerry Younger; Ulysses Balis; James Michaelson; Atul Bhan; Karleen Habin; Thomas M Baer; Joan Brugge; Daniel A Haber; Mark G Erlander; Dennis C Sgroi
Journal:  Cancer Cell       Date:  2004-06       Impact factor: 31.743

4.  In vivo expression of the whole HOX gene network in human breast cancer.

Authors:  M Cantile; G Pettinato; A Procino; I Feliciello; L Cindolo; C Cillo
Journal:  Eur J Cancer       Date:  2003-01       Impact factor: 9.162
  4 in total
  16 in total

1.  The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.

Authors:  Jennifer L Beebe-Dimmer; Matthew Hathcock; Cecilia Yee; Linda A Okoth; Charles M Ewing; William B Isaacs; Kathleen A Cooney; Stephen N Thibodeau
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06-24       Impact factor: 4.254

2.  Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.

Authors:  Kara N Maxwell; Steven N Hart; Joseph Vijai; Kasmintan A Schrader; Thomas P Slavin; Tinu Thomas; Bradley Wubbenhorst; Vignesh Ravichandran; Raymond M Moore; Chunling Hu; Lucia Guidugli; Brandon Wenz; Susan M Domchek; Mark E Robson; Csilla Szabo; Susan L Neuhausen; Jeffrey N Weitzel; Kenneth Offit; Fergus J Couch; Katherine L Nathanson
Journal:  Am J Hum Genet       Date:  2016-05-05       Impact factor: 11.025

3.  Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer.

Authors:  Mohammad R Akbari; Laura N Anderson; Daniel D Buchanan; Mark Clendenning; Mark A Jenkins; Aung Ko Win; John L Hopper; Graham G Giles; Robert Nam; Steven Narod; Steven Gallinger; Sean P Cleary
Journal:  Cancer Epidemiol       Date:  2013-03-26       Impact factor: 2.984

4.  Putative linkage signals identified for breast cancer in African American families.

Authors:  Heather M Ochs-Balcom; Xiangqing Sun; Yanwen Chen; Jill Barnholtz-Sloan; Deborah O Erwin; Lina Jandorf; Lara Sucheston-Campbell; Robert C Elston
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12-04       Impact factor: 4.254

5.  A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.

Authors:  Joseph Vijai; Sabine Topka; Danylo Villano; Vignesh Ravichandran; Kara N Maxwell; Ann Maria; Tinu Thomas; Pragna Gaddam; Anne Lincoln; Sarah Kazzaz; Brandon Wenz; Shai Carmi; Kasmintan A Schrader; Steven N Hart; Steve M Lipkin; Susan L Neuhausen; Michael F Walsh; Liying Zhang; Flavio Lejbkowicz; Hedy Rennert; Zsofia K Stadler; Mark Robson; Jeffrey N Weitzel; Susan Domchek; Mark J Daly; Fergus J Couch; Katherine L Nathanson; Larry Norton; Gad Rennert; Kenneth Offit
Journal:  Cancer Discov       Date:  2016-09-21       Impact factor: 39.397

6.  HOXB13 mutation and prostate cancer: studies of siblings and aggressive disease.

Authors:  John S Witte; Joel Mefford; Sarah J Plummer; Jinghua Liu; Iona Cheng; Eric A Klein; Benjamin A Rybicki; Graham Casey
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-02-08       Impact factor: 4.254

Review 7.  HOX genes: Major actors in resistance to selective endocrine response modifiers.

Authors:  Kideok Jin; Saraswati Sukumar
Journal:  Biochim Biophys Acta       Date:  2016-01-22

8.  Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy.

Authors:  Jennifer L Beebe-Dimmer; William B Isaacs; Kimberly A Zuhlke; Cecilia Yee; Patrick C Walsh; Sarah D Isaacs; Anna M Johnson; Charles E Ewing; Elizabeth B Humphreys; Wasim H Chowdhury; James E Montie; Kathleen A Cooney
Journal:  BJU Int       Date:  2014-03-05       Impact factor: 5.588

9.  Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort.

Authors:  Thomas J Hoffmann; Lori C Sakoda; Ling Shen; Eric Jorgenson; Laurel A Habel; Jinghua Liu; Mark N Kvale; Maryam M Asgari; Yambazi Banda; Douglas Corley; Lawrence H Kushi; Charles P Quesenberry; Catherine Schaefer; Stephen K Van Den Eeden; Neil Risch; John S Witte
Journal:  PLoS Genet       Date:  2015-01-28       Impact factor: 5.917

10.  The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer.

Authors:  Mohammad R Akbari; Wojciech Kluźniak; Rachelle Rodin; Song Li; Dominika Wokołorczyk; Robert Royer; Aniruddh Kashyap; Janusz Menkiszak; Jan Lubinski; Steven A Narod; Cezary Cybulski
Journal:  Breast Cancer Res Treat       Date:  2012-10-26       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.